HealthNotableSingle-source
5.4
Japan approves world-first oncolytic virus therapy for esophageal cancer
Nikkei Asia·JP·3 days ago
Researchers at Tel Aviv University are nearing the first human clinical trial of a spinal cord implant designed to restore mobility in paralyzed patients. While the technology aims to enable standing and walking, the timeline for the initial procedure and the specific patient criteria remain unconfirmed.
Locations
Entities